Cara Therapeutics, Inc. (NASDAQ:CARA) Q2 2023 Earnings Call Transcript August 7, 2023 Cara Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.00058 EPS, expectations were $0.56. Operator: Thank you for standing by, and welcome to Cara Therapeutics’ Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. [Operator Instructions]. […]
Lexicon Pharmaceuticals, Inc. (NASDAQ:NASDAQ:LXRX) Q3 2022 Earnings Conference Call November 09, 2022 5:00 PM ET Company Participants Mike Kelly – Investor Relations Lonnel Coats – Chief.